Literature DB >> 8205839

Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types.

H zur Hausen1.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8205839     DOI： 10.1007/978-3-642-78487-3_8

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  70 in total

1.  The E8 domain confers a novel long-distance transcriptional repression activity on the E8E2C protein of high-risk human papillomavirus type 31.

Authors:  F Stubenrauch; T Zobel; T Iftner
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope.

Authors:  R B Roden; A Armstrong; P Haderer; N D Christensen; N L Hubbert; D R Lowy; J T Schiller; R Kirnbauer
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

3.  Detection and typing of human papillomaviruses by polymerase chain reaction in cervical scrapes of Croatian women with abnormal cytology.

Authors:  M Grce; K Husnjak; L Magdić; M Ilijas; M Zlacki; D Lepusić; J Lukac; B Hodek; V Grizelj; A Kurjak; Z Kusić; K Pavelić
Journal:  Eur J Epidemiol       Date:  1997-09       Impact factor: 8.082

4.  A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings.

Authors:  M V Jacobs; P J Snijders; A J van den Brule; T J Helmerhorst; C J Meijer; J M Walboomers
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

5.  Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri.

Authors:  L Riethdorf; S Riethdorf; K Gützlaff; F Prall; T Löning
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

6.  Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions.

Authors:  F Stubenrauch; A M Colbert; L A Laimins
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease.

Authors:  Jon D Reuter; Beatriz E Vivas-Gonzalez; Daniel Gomez; Jean H Wilson; Janet L Brandsma; Heather L Greenstone; John K Rose; Anjeanette Roberts
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture.

Authors:  M H Schiffman; N B Kiviat; R D Burk; K V Shah; R W Daniel; R Lewis; J Kuypers; M M Manos; D R Scott; M E Sherman
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

9.  Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies.

Authors:  R C Rose; W I White; M Li; J A Suzich; C Lane; R L Garcea
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Identification of a differentiation-inducible promoter in the E7 open reading frame of human papillomavirus type 16 (HPV-16) in raft cultures of a new cell line containing high copy numbers of episomal HPV-16 DNA.

Authors:  K Grassmann; B Rapp; H Maschek; K U Petry; T Iftner
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.